ACU Expands Direct-to-Consumer Capabilities with $18.7M My Medic Acquisition—Aiming for Growth in Tactical and Emergency Response Markets
Acquisition Adds $19 Million in Annual Revenue and Strong Digital Reach
Acme United Corporation (NYSE:ACU) has announced the acquisition of the assets of SLED Distribution, LLC, better known as "My Medic," in a deal valued at $18.7 million. My Medic, based in North Salt Lake, Utah, is a notable supplier of tactical, trauma, and emergency response products—primarily selling direct-to-consumer. The newly acquired business recorded approximately $19 million in revenue for 2025 and employs 40 staff.
This move brings not just a product lineup, but a powerful digital presence: My Medic boasts an extensive library of training videos and over 500,000 followers across its social platforms. According to ACU's management, this direct consumer engagement is considered the strongest for trauma and emergency products in the United States.
Deal Structure Stresses Performance and Integration
The acquisition price includes an upfront payment of $14.6 million, with another $4.1 million contingent on revenue milestones and indemnification holdbacks. The company plans to keep My Medic’s operations in Utah and to broaden its reach in both the U.S. and Canada. This highlights ACU’s intent to leverage My Medic’s direct-to-consumer strength and scale its brand further.
| Acquisition Details | Amount (USD) |
|---|---|
| Purchase Price | $18.70 million |
| Initial Payment | $14.60 million |
| Contingent/Holdback | $4.10 million |
| 2025 My Medic Revenue | $19.00 million |
Focus Remains on Expansion and Direct Consumer Access
ACU's management sees significant opportunity from combining marketing, sourcing, and manufacturing platforms. By acquiring a brand with a large established fanbase and training footprint, ACU is positioning itself for deeper penetration in both the tactical and emergency response arenas. Continued investment in product offering and distribution—especially in North America—could strengthen the company's competitive edge as consumer habits shift toward digital-first purchasing.
Key Takeaway: Deal Targets Growth and Resilience Amid Broader Market Uncertainty
While Acme United continues to face the typical risks associated with integration, supply chain disruption, and evolving consumer habits, this acquisition brings an immediate boost to its revenue base and offers a scalable Direct-to-Consumer (DTC) platform. For investors and industry watchers alike, tracking ACU’s progress on integrating My Medic—and expanding its digital and retail footprint—will reveal whether this strategic pivot yields outsized returns in a rapidly shifting sector.
| Current Stock Data | Value |
|---|---|
| Price (10:21 AM) | $43.50 |
| Price Change | -$0.42 |
| Percent Change | -0.96% |
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI